Relapsed/Refractory Rhabdomyosarcoma

1 clinical trials · Condition

Record	Firm	Date
Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS) (NCT03441360)	Eisai Inc.	2018-04-17

Every clearance here is in the API, with alerts when new ones post.